Blood Tests for Heart Risk in People on Dialysis
Checks two blood markers, CRP and D-dimer, in adult dialysis patients for heart risk.
Plain-language title generated from the registry record
Registry title: Assessment of D-dimer and CRP for Cardiovascular Risk Prediction in Hemodialysis Patients
Key facts
- Where
- Asyut, EgyptSee the site
Where in Egypt
- Assiut University hospitalAsyut, EgyptNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Assiut University
- Trial code
- NCT07130721
- Record updated
- 19 August 2025
- Original description
This study aims to assess whether two blood markers - C-reactive protein (CRP) and D-dimer - can help predict cardiovascular complications in patients undergoing regular hemodialysis. Cardiovascular disease is a common and serious problem in dialysis patients, and early detection is important.Read full original descriptionShow less
Assessment of Blood Biomarkers (D-dimer and C-Reactive Protein) in Predicting Cardiovascular Complications Among Hemodialysis Patients: A Cross-Sectional Study
This study aims to assess whether two blood markers - C-reactive protein (CRP) and D-dimer - can help predict cardiovascular complications in patients undergoing regular hemodialysis. Cardiovascular disease is a common and serious problem in dialysis patients, and early detection is important.
the study will include 100 adult patients from the Hemodialysis Unit at Assiut University Hospital. Participants will be divided into two groups: those with and those without known heart disease. Each participant will have a one-time blood test to measure CRP and D-dimer levels. In addition, an electrocardiogram (ECG) will be done once to check for signs of heart problems.
Inclusion: Adults aged ≥18 years; On regular hemodialysis for at least 3 months; Able and willing to provide informed consent; Group I: Hemodialysis patients with no clinically documented cardiovascular disease; Group II: Hemodialysis patients with confirmed cardiovascular disease (by medical records, ECGs, echocardiography, or documented hospital admissions).
Exclusion: Acute or recent infection (within the past 4 weeks); Use of anticoagulant or antiplatelet therapy; Active malignancy; Autoimmune or chronic inflammatory disease; Known bleeding or thrombotic disorders; Pregnancy.